This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Holmes, D. R. Articles by Berger, P. B. Search for Related Content PubMed PubMed Citation Articles by Holmes, D. R., Jr Articles by Berger, P. B. Related Collections Coronary imaging: angiography/ultrasound/Doppler/CC CV surgery: coronary artery disease

(Circulation. 1999;99:8-11.)
© 1999 American Heart Association, Inc.

Editorial

Percutaneous Revascularization of Occluded Vein Grafts

Is It Still a Temptation to Be Resisted?

David R. Holmes, Jr, MD; Peter B. Berger, MD

From Mayo Clinic, Rochester, Minn.

Correspondence to David R. Holmes, MD, Cardiovascular Diseases and Internal Medicine, Mayo Clinic, 200 First St SW, Rochester, MN 55905.

Key Words: Editorials • revascularization • occlusion • thrombolysis • ultrasonics • bypass grafts

Given the number of patients who have undergone coronary bypass surgery in which vein grafts were used, the increasing incidence of vein graft disease over time, and the reluctance of most patients to see a cardiovascular surgeon professionally again after the first go-around, there is continued need for development of approaches to treat such patients. There are many unique characteristics of patients treated for vein graft disease: they are older than when they had their initial procedure, and more importantly, their vein grafts are also older. Beyond 1 year and particularly >3 years after surgery, atherosclerosis of vein grafts becomes increasingly prevalent.^{1 2 3 4 5} It may coexist with intimal fibromuscular proliferation and, in patients with acute ischemic syndromes, thrombus of varying ages. Atherosclerotic plaques in vein grafts are often large compared with plaques in native coronary arteries and are usually soft and friable, rich in necrotic debris, cholesterol crystals, blood elements, and foam cells; this is often referred to as gruel. Thrombus has been documented by angioscopy in up to 70% of vein graft lesions undergoing treatment.⁶ This substrate is primarily responsible for the problems encountered during interventional procedures, which include distal embolization, inadequate dilatation, and increased restenosis rates.

Distal embolization is of the greatest concern because the treatment options for embolization are so limited. Saber et al⁷ assessed the histopathology of 6 vein grafts from 5 patients treated with balloon angioplasty. Two grafts were obtained during autopsy; the remainder were from surgical extirpation. The picture worth a thousand words (Figure) . . . [Full Text of this Article]

This article has been cited by other articles:

				T. M. Patel, S. C. Shah, and A. Ranjan Unusual Retrograde Aortic Arch Dissection During Percutaneous Coronary Intervention: A Case Report Angiology, August 1, 2006; 57(4): 501 - 505. [Abstract] [PDF]

				V. Schachinger, C. W. Hamm, T. Munzel, M. Haude, S. Baldus, E. Grube, T. Bonzel, T. Konorza, R. Koster, R. Arnold, et al. A randomized trial of polytetrafluoroethylene-membrane-covered stents compared with conventional stents in aortocoronary saphenous vein grafts J. Am. Coll. Cardiol., October 15, 2003; 42(8): 1360 - 1369. [Abstract] [Full Text] [PDF]

				P. P. Hujoel, M. Drangsholt, C. Spiekerman, and T. A. DeRouen Periodontal Disease and Coronary Heart Disease Risk JAMA, September 20, 2000; 284(11): 1406 - 1410. [Abstract] [Full Text] [PDF]

				R. Choussat, A. J. R. Black, I. Bossi, T. Joseph, J. Fajadet, and J. Marco Long-term clinical outcome after endoluminal reconstruction of diffusely degenerated saphenous vein grafts with less-shortening wallstents J. Am. Coll. Cardiol., August 1, 2000; 36(2): 387 - 394. [Abstract] [Full Text] [PDF]